Aceso Life Science Group Limited risk profile
73 Stretched several inputs deteriorating together
Measured 21 October 2026 from 0474.HK's filed statements. Recomputed nightly.
73 (Stretched), driven by Competitive position at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 52 | Elevated | Volatile | One-year price volatility — 50.2% |
| Operating pressure | 37 | Normal | Easing | Operating-margin drift — -44.8 percentage points |
| Cash conversion | 47 | Elevated | Worsening | Cash conversion — 0.06x |
| Leverage and coverage | 86 | Acute | Easing | Net debt to EBITDA |
| Competitive position | 100 | Acute | Stable | Operating-margin gap against peers — -45.5 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Industrials companies with a risk reading
Space Exploration Technologies Corp. 65Caterpillar Inc 44General Electric Company 44RTX Corp 49GE Vernova LLC 42ABB Ltd 42Union Pacific Corp 49Deere & Company 48Schneider Electric SE 45Hitachi, Ltd. 45Eaton Corporation plc 50Boeing Company 52
Financials, valuation and price history for Aceso Life Science Group Limited